|
1
|
Gyorki DE, Callahan M, Wolchok JD and
Ariyan CE: The delicate balance of melanoma immunotherapy. Clin
Transl Immunology. 2:e52013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yee C, Thompson J, Byrd D, et al: Adoptive
T cell therapy using antigen-specific CD8+ T cell clones for the
treatment of patients with metastatic melanoma: In vivo
persistence, migration, and antitumor effect of transferred T
cells. Proc Natl Acad Sci USA. 99:16168–16173. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cui NP, XIE SJ, Han JS, et al: Effective
adoptive transfer of haploidentical tumor-specific T cells in
B16-melanoma bearing mice. Chin Med J (Engl). 125:794–800.
2012.PubMed/NCBI
|
|
4
|
Chiu HY, Sun GH, Chen SY, et al:
Pre-existing Fas ligand (FasL) in cancer cells elicits
tumor-specific protective immunity, but delayed induction of FasL
expression after inoculation facilitates tumor formation. Mol
Carcinog. 52:705–714. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ardolino M, Azimi CS, Iannello A, et al:
Cytokine therapy reverses NK cell anergy in MHC-deficient tumors. J
Clin Invest. 124:4781–4794. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mkrtichyan M, Ghochikyan A, Davtyan H, et
al: Cancer-testis antigen, BORIS based vaccine delivered by
dendritic cells is extremely effective against a very aggressive
and highly metastatic mouse mammary carcinoma. Cell Immunol.
270:188–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Burdek M, Spranger S, Wilde S, et al:
Three-day dendritic cells for vaccine development: antigen uptake,
processing and presentation. J Transl Med. 8:902010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Parry AL, Clemson NA, Ellis J, et al:
‘Multicopy multivalent’ glycopolymer-stabilised gold nanoparticles
as potential synthetic cancer vaccines. J Am Chem Soc.
135:9362–9365. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hunn MK, Farrand KJ, Broadley KW, et al:
Vaccination with irradiated tumor cells pulsed with an adjuvant
that stimulates NKT cells is an effective treatment for glioma.
Clin Cancer Res. 18:6446–6459. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Teitz-Tennenbaum S, Li Q, Davis MA and
Chang AE: Dendritic cells pulsed with keyhole limpet hemocyanin and
cryopreserved maintain anti-tumor activity in a murine melanoma
model. Clin Immunol. 129:482–491. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chiang CL, Kandalaft LE, Tanyi J, et al: A
dendritic cell vaccine pulsed with autologous hypochlorous
acid-oxidized ovarian cancer lysate primes effective broad
antitumor immunity: from bench to bedside. Clin Cancer Res.
19:4801–4815. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Obata C, Zhang M, Moroi Y, et al:
Formalin-fixed tumor cells effectively induce antitumor immunity
both in prophylactic and therapeutic conditions. J Dermatol Sci.
34:209–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Clay TM, Mosca PJ, Lyerly HK and Morse MA:
Whole-tumor-cell vaccinesHandbook of Cancer Vaccines. Morse MA,
Clay TM and Lyerly HK: Springer; pp. 249–251. 2004
|
|
14
|
Koido S, Homma S, Okamoto M, et al:
Fusions between dendritic cells and whole tumor cells as anticancer
vaccines. Oncoimmunology. 2:e244372013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu P and Fu YX: Tumor-infiltrating T
lymphocytes: friends or foes? Laboratory Invest. 86:231–245. 2006.
View Article : Google Scholar
|
|
16
|
Sharma P, Shen Y, Wen S, et al: CD8
tumor-infiltrating lymphocytes are predictive of survival in
muscle-invasive urothelial carcinoma. Proc Natl Acad Sci USA.
104:3967–3972. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Clemente CG, Mihm MC Jr, Bufalino R, et
al: Prognostic value of tumor infiltrating lymphocytes in the
vertical growth phase of primary cutaneous melanoma. Cancer.
77:1303–1310. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aerts JG and Hegmans JP: Tumor-specific
cytotoxic T cells are crucial for efficacy of immunomodulatory
antibodies in patients with lung cancer. Cancer Res. 73:2381–2388.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dudley ME, Wunderlich JR, Robbins PF, et
al: Cancer regression and autoimmunity in patients after clonal
repopulation with antitumor lymphocytes. Science. 298:850–854.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sakaguchi S, Yamaguchi T, Nomura T and Ono
M: Regulatory T cells and immune tolerance. Cell. 133:775–787.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu WK, Ho JC, Cheung FW, et al: Apoptotic
activity of betulinic acid derivatives on murine melanoma B16 cell
line. Eur J Pharmacol. 498:71–78. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eggermont AM: Therapeutic vaccines in
solid tumours: can they be harmful? Eur J Cancer. 45:2087–2090.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pajtasz-Piasecka E and Indrová M:
Dendritic cell-based vaccines for the therapy of experimental
tumors. Immunotherapy. 2:257–268. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hira SK, Mondal I and Manna PP: Combined
immunotherapy with whole tumor lysate-pulsed
interleukin-15-activated dendritic cells and cucurbitacin I
promotes strong CD8(+) T-cell responses and cures highly aggressive
lymphoma. Cytotherapy. 17:647–664. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Manzo T, Michelini RH, Sturmheit T, et al:
Tumor-targeting vaccination instructs graft-vs.-tumor immune
responses. Oncoimmunology. 2:e259962013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu J, Fu W, Luo J and Zhang T: Expression
and purification of human endostatin from Hansenula polymorpha A16.
Protein Expr Purif. 42:12–19. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kósa JP, Horváth P, Wölfling J, et al:
CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3
on colorectal cancer cells. World J Gastroenterol. 19:2621–2628.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zamarron BF and Chen WJ: Dual roles of
immune cells and their factors in cancer development and
progression. Int J Biol Sci. 7:651–658. 2011. View Article : Google Scholar : PubMed/NCBI
|
